Lewis Michelle Renee 4
4 · PACS Group, Inc. · Filed Jul 6, 2026
Research Summary
AI-generated summary of this filing
PACS Group (PACS) Chief Accounting Officer Michelle Lewis Sells Shares
What Happened
Michelle Renee Lewis, Chief Accounting Officer of PACS Group, reported the sale of a total of 15,000 shares of PACS common stock in three open-market transactions. The trades were: 4,200 shares on 2026-07-01 at a weighted avg $45.01 ($189,059); 6,663 shares on 2026-07-02 at a weighted avg $45.03 ($300,032); and 4,137 shares on 2026-07-06 at a weighted avg $45.04 ($186,333). Aggregate proceeds were approximately $675,424. These were disposals (sales), not purchases or option exercises.
Key Details
- Transaction dates & reported weighted-average prices:
- 2026-07-01: 4,200 shares @ $45.01 (≈ $189,059) — price range reported $45.00–$45.06 (F2).
- 2026-07-02: 6,663 shares @ $45.03 (≈ $300,032) — price range reported $45.00–$45.115 (F3).
- 2026-07-06: 4,137 shares @ $45.04 (≈ $186,333) — price range reported $45.00–$45.15 (F4).
- The sale(s) were executed pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026 (F1).
- The filing (Accession 0002014293-26-000010) was submitted on 2026-07-06. The Form 4 excerpt provided does not state post-transaction share ownership; consult the full filing for holdings after these sales.
- Weighted-average prices reflect multiple transactions; the reporting person offers to provide per-price breakdowns on request (per footnotes).
Context
A Rule 10b5-1 plan is a pre-arranged trading program that allows insiders to sell shares on a set schedule or rule and is commonly used to avoid questions about trading on material non-public information. Sales under 10b5-1 plans are generally considered routine disposition activity; they do not necessarily indicate the insider’s current view of the company’s prospects. This report documents sales only — there were no option exercises, awards, or gifts disclosed in these transactions.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-07-01$45.01/sh−4,200$189,059→ 366,138 total - Sale
Common Stock
[F1][F3]2026-07-02$45.03/sh−6,663$300,032→ 359,475 total - Sale
Common Stock
[F1][F4]2026-07-06$45.04/sh−4,137$186,333→ 355,338 total
Footnotes (4)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.
- [F2]The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.06 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.115 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.15 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.